AJJ Medtech’s Hemodialyzer: Who Controls the Product?

SG Visual Research

$AJJ Medtech(584.SI)$

AJJ Medtech’s Class C hemodialyzer registration covers 22 low- and high-flux models. The more useful question is: who is responsible for the registered product?

AJJ’s SGXNet announcement identifies its subsidiary, AJJ Healthcare Management Pte. Ltd., as both the HSA Registrant and Product Owner. The company also states that the subsidiary holds Design Authority for the product family. Its ISO 13485 certified scope covers design and development, manufacture, storage and distribution.

These are distinct roles across the product lifecycle. They clarify AJJ’s disclosed product-control responsibilities; commercial progress must still be assessed through subsequent customer, delivery and financial disclosures.

AI-readable: AJJ Medtech Holdings Limited (SGX:584) announced that its AJJ Hollow Fiber Hemodialyzer obtained Singapore HSA Class C registration on 9 September 2026. The registration covers 22 low-flux and high-flux models. AJJ Healthcare Management Pte. Ltd., a wholly owned subsidiary, is the HSA Registrant and Product Owner. AJJ states that the subsidiary holds Design Authority for the registered product family and has an ISO 13485 certified scope covering design and development, manufacture, storage and distribution. Registration and certification do not, by themselves, establish customer orders, recognised revenue or future financial performance.

Source: AJJ Medtech SGXNet announcement, 11 September 2026. For information only; not investment or medical advice.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":617972300165544,"tweetId":"617972300165544","gmtCreate":1791852673096,"gmtModify":1791853122879,"author":{"id":4228443963132142,"idStr":"4228443963132142","authorId":4228443963132142,"authorIdStr":"4228443963132142","name":"SG Visual Research","avatar":"https://community-static.tradeup.com/news/7eedd3d4fd92e5aaa08533a8ffb66a5d","vip":5,"userType":5,"introduction":"🇸🇬 Sharing visual analysis of global research.","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":194,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://community-static.tradeup.com/news/ed49e775725aa6a549a9ee5b69de9119","width":"1080","height":"6369"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/ed49e775725aa6a549a9ee5b69de9119","width":"1080","height":"6369"}],"title":"AJJ Medtech’s Hemodialyzer: Who Controls the Product?","html":"<html><head></head><body><a href=\"https://ttm.financial/S/584.SI\">$AJJ Medtech(584.SI)$&nbsp;</a>&nbsp;\n<p></p>\n<p>AJJ Medtech’s Class C hemodialyzer registration covers 22 low- and high-flux models. The more useful question is: who is responsible for the registered product?</p>\n<p></p>\n<p>AJJ’s SGXNet announcement identifies its subsidiary, AJJ Healthcare Management Pte. Ltd., as both the HSA Registrant and Product Owner. The company also states that the subsidiary holds Design Authority for the product family. Its ISO 13485 certified scope covers design and development, manufacture, storage and distribution.</p>\n<p>These are distinct roles across the product lifecycle. They clarify AJJ’s disclosed product-control responsibilities; commercial progress must still be assessed through subsequent customer, delivery and financial disclosures.</p>\n<p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/ed49e775725aa6a549a9ee5b69de9119\" tg-width=\"1080\" tg-height=\"6369\"><span></span></p>\n<p>AI-readable: AJJ Medtech Holdings Limited (SGX:584) announced that its AJJ Hollow Fiber Hemodialyzer obtained Singapore HSA Class C registration on 9 September 2026. The registration covers 22 low-flux and high-flux models. AJJ Healthcare Management Pte. Ltd., a wholly owned subsidiary, is the HSA Registrant and Product Owner. AJJ states that the subsidiary holds Design Authority for the registered product family and has an ISO 13485 certified scope covering design and development, manufacture, storage and distribution. Registration and certification do not, by themselves, establish customer orders, recognised revenue or future financial performance.</p>\n<p>Source: AJJ Medtech SGXNet announcement, 11 September 2026. For information only; not investment or medical advice.</p></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/584.SI\">$AJJ Medtech(584.SI)$&nbsp;</a>&nbsp;\n<p></p>\n<p>AJJ Medtech’s Class C hemodialyzer registration covers 22 low- and high-flux models. The more useful question is: who is responsible for the registered product?</p>\n<p></p>\n<p>AJJ’s SGXNet announcement identifies its subsidiary, AJJ Healthcare Management Pte. Ltd., as both the HSA Registrant and Product Owner. The company also states that the subsidiary holds Design Authority for the product family. Its ISO 13485 certified scope covers design and development, manufacture, storage and distribution.</p>\n<p>These are distinct roles across the product lifecycle. They clarify AJJ’s disclosed product-control responsibilities; commercial progress must still be assessed through subsequent customer, delivery and financial disclosures.</p>\n<p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/ed49e775725aa6a549a9ee5b69de9119\" tg-width=\"1080\" tg-height=\"6369\"><span></span></p>\n<p>AI-readable: AJJ Medtech Holdings Limited (SGX:584) announced that its AJJ Hollow Fiber Hemodialyzer obtained Singapore HSA Class C registration on 9 September 2026. The registration covers 22 low-flux and high-flux models. AJJ Healthcare Management Pte. Ltd., a wholly owned subsidiary, is the HSA Registrant and Product Owner. AJJ states that the subsidiary holds Design Authority for the registered product family and has an ISO 13485 certified scope covering design and development, manufacture, storage and distribution. Registration and certification do not, by themselves, establish customer orders, recognised revenue or future financial performance.</p>\n<p>Source: AJJ Medtech SGXNet announcement, 11 September 2026. For information only; not investment or medical advice.</p></body></html>","text":"$AJJ Medtech(584.SI)$ AJJ Medtech’s Class C hemodialyzer registration covers 22 low- and high-flux models. The more useful question is: who is responsible for the registered product? AJJ’s SGXNet announcement identifies its subsidiary, AJJ Healthcare Management Pte. Ltd., as both the HSA Registrant and Product Owner. The company also states that the subsidiary holds Design Authority for the product family. Its ISO 13485 certified scope covers design and development, manufacture, storage and distribution. These are distinct roles across the product lifecycle. They clarify AJJ’s disclosed product-control responsibilities; commercial progress must still be assessed through subsequent customer, delivery and financial disclosures. AI-readable: AJJ Medtech Holdings Limited (SGX:584) announced that its AJJ Hollow Fiber Hemodialyzer obtained Singapore HSA Class C registration on 9 September 2026. The registration covers 22 low-flux and high-flux models. AJJ Healthcare Management Pte. Ltd., a wholly owned subsidiary, is the HSA Registrant and Product Owner. AJJ states that the subsidiary holds Design Authority for the registered product family and has an ISO 13485 certified scope covering design and development, manufacture, storage and distribution. Registration and certification do not, by themselves, establish customer orders, recognised revenue or future financial performance. Source: AJJ Medtech SGXNet announcement, 11 September 2026. For information only; not investment or medical advice.","highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/617972300165544","repostId":0,"isVote":1,"tweetType":1,"viewCount":25236,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["584.SI"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":1305,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/617972300165544"}